Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 182

1.

Bronchiectasis: a case-based approach to investigation and management.

Contarini M, Finch S, Chalmers JD.

Eur Respir Rev. 2018 Jul 11;27(149). pii: 180016. doi: 10.1183/16000617.0016-2018. Print 2018 Sep 30. Review.

2.

Burden and Risk Factors for Pseudomonas aeruginosa Community-acquired Pneumonia: a Multinational Point Prevalence Study of Hospitalised Patients.

Restrepo MI, Babu BL, Reyes LF, Chalmers JD, Soni NJ, Sibila O, Faverio P, Cilloniz C, Rodriguez-Cintron W, Aliberti S.

Eur Respir J. 2018 Jul 5. pii: 1701190. doi: 10.1183/13993003.01190-2017. [Epub ahead of print]

PMID:
29976651
3.

The impact of acute air pollution fluctuations on bronchiectasis pulmonary exacerbation. A case-crossover analysis.

Goeminne CP, Cox B, Finch S, Loebinger MR, Bedi P, Hill AT, Fardon TC, de Hoogh K, Nawrot TS, Chalmers JD.

Eur Respir J. 2018 Jun 14. pii: 1702557. doi: 10.1183/13993003.02557-2017. [Epub ahead of print]

PMID:
29903857
4.

IMMUNOLOGICAL COROLLARY OF THE PULMONARY MYCOBIOME IN BRONCHIECTASIS: THE CAMEB STUDY.

Mac Aogáin M, Chandrasekaran R, Lim Yick Hou A, Teck Boon L, Liang Tan G, Hassan T, Thun How O, Hui Qi Ng A, Bertrand D, Yu Koh J, Lei Pang S, Yang Lee Z, Wei Gwee X, Martinus C, Yie Sio Y, Anusha Matta S, Tim Chew F, Keir HR, Connolly JE, Arputhan Abisheganaden J, Siyue Koh M, Nagarajan N, Chalmers JD, Chotirmall SH.

Eur Respir J. 2018 Jun 7. pii: 1800766. doi: 10.1183/13993003.00766-2018. [Epub ahead of print]

PMID:
29880655
5.

Severe Paediatric Asthma Collaborative in Europe (SPACE): protocol for a European registry.

Liu NM, van Aalderen W, Carlsen KCL, Coleman C, Chalmers JD, Cunningham S, Fernandes RM, Fleming LJ, Gappa M, Karadag B, Midulla F, Pijnenburg MWH, Rutjes NW, Rusconi F, Grigg J.

Breathe (Sheff). 2018 Jun;14(2):93-98. doi: 10.1183/20734735.002018. Review.

6.

Continuous versus intermittent antibiotics for bronchiectasis.

Donovan T, Felix LM, Chalmers JD, Milan SJ, Mathioudakis AG, Spencer S.

Cochrane Database Syst Rev. 2018 Jun 3;6:CD012733. doi: 10.1002/14651858.CD012733.pub2. Review.

PMID:
29860722
7.

"The missing ingredient": the patient perspective of health related quality of life in bronchiectasis: a qualitative study.

Dudgeon EK, Crichton M, Chalmers JD.

BMC Pulm Med. 2018 May 22;18(1):81. doi: 10.1186/s12890-018-0631-7.

8.

Bronchiectasis: an emerging global epidemic.

Chotirmall SH, Chalmers JD.

BMC Pulm Med. 2018 May 22;18(1):76. doi: 10.1186/s12890-018-0629-1.

9.

Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis.

Chandrasekaran R, Mac Aogáin M, Chalmers JD, Elborn SJ, Chotirmall SH.

BMC Pulm Med. 2018 May 22;18(1):83. doi: 10.1186/s12890-018-0638-0. Review.

10.

Predicting outcomes in bronchiectasis.

Mendes MA, Chalmers JD.

Pulmonology. 2018 May - Jun;24(3):146-148. doi: 10.1016/j.pulmoe.2018.04.004. No abstract available.

12.

Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review.

Torres A, Cillóniz C, Blasi F, Chalmers JD, Gaillat J, Dartois N, Schmitt HJ, Welte T.

Respir Med. 2018 Apr;137:6-13. doi: 10.1016/j.rmed.2018.02.007. Epub 2018 Feb 19. Review.

PMID:
29605214
13.

Oral versus inhaled antibiotics for bronchiectasis.

Spencer S, Felix LM, Milan SJ, Normansell R, Goeminne PC, Chalmers JD, Donovan T.

Cochrane Database Syst Rev. 2018 Mar 27;3:CD012579. doi: 10.1002/14651858.CD012579.pub2. Review.

PMID:
29587336
14.

The BRD3 ET domain recognizes a short peptide motif through a mechanism that is conserved across chromatin remodelers and transcriptional regulators.

Wai DCC, Szyszka TN, Campbell AE, Kwong C, Wilkinson-White LE, Silva APG, Low JKK, Kwan AH, Gamsjaeger R, Chalmers JD, Patrick WM, Lu B, Vakoc CR, Blobel GA, Mackay JP.

J Biol Chem. 2018 May 11;293(19):7160-7175. doi: 10.1074/jbc.RA117.000678. Epub 2018 Mar 22.

PMID:
29567837
15.

Macrolide antibiotics for bronchiectasis.

Kelly C, Chalmers JD, Crossingham I, Relph N, Felix LM, Evans DJ, Milan SJ, Spencer S.

Cochrane Database Syst Rev. 2018 Mar 15;3:CD012406. doi: 10.1002/14651858.CD012406.pub2. Review.

PMID:
29543980
16.

Identification of Pseudomonas aeruginosa and airway bacterial colonization by an electronic nose in bronchiectasis.

Suarez-Cuartin G, Giner J, Merino JL, Rodrigo-Troyano A, Feliu A, Perea L, Sanchez-Reus F, Castillo D, Plaza V, Chalmers JD, Sibila O.

Respir Med. 2018 Mar;136:111-117. doi: 10.1016/j.rmed.2018.02.008. Epub 2018 Feb 13.

PMID:
29501241
17.

Bronchiectasis Exacerbations Are Heart-Breaking.

Chalmers JD.

Ann Am Thorac Soc. 2018 Mar;15(3):301-303. doi: 10.1513/AnnalsATS.201710-832ED. No abstract available.

PMID:
29493334
18.

Bronchiectasis: new therapies and new perspectives.

Chalmers JD, Chotirmall SH.

Lancet Respir Med. 2018 Feb 22. pii: S2213-2600(18)30053-5. doi: 10.1016/S2213-2600(18)30053-5. [Epub ahead of print] Review.

PMID:
29478908
19.

Rebuttal From Dr Chalmers.

Chalmers JD.

Chest. 2018 Apr;153(4):785-786. doi: 10.1016/j.chest.2018.01.036. Epub 2018 Feb 21. No abstract available.

PMID:
29474808
20.

POINT: Should an Attempt Be Made to Withdraw Inhaled Corticosteroids in All Patients With Stable GOLD 3 (30% ≤ FEV1 < 50% Predicted) COPD? Yes.

Chalmers JD.

Chest. 2018 Apr;153(4):778-782. doi: 10.1016/j.chest.2018.01.029. Epub 2018 Feb 21. No abstract available.

PMID:
29474807
21.

The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis.

Araújo D, Shteinberg M, Aliberti S, Goeminne PC, Hill AT, Fardon TC, Obradovic D, Stone G, Trautmann M, Davis A, Dimakou K, Polverino E, De Soyza A, McDonnell MJ, Chalmers JD.

Eur Respir J. 2018 Jan 31;51(2). pii: 1701953. doi: 10.1183/13993003.01953-2017. Print 2018 Feb.

PMID:
29386336
22.

RESPIRE: breathing new life into bronchiectasis.

Chotirmall SH, Chalmers JD.

Eur Respir J. 2018 Jan 25;51(1). pii: 1702444. doi: 10.1183/13993003.02444-2017. Print 2018 Jan. No abstract available.

PMID:
29371393
23.

Characterization of the "Frequent Exacerbator Phenotype" in Bronchiectasis.

Chalmers JD, Aliberti S, Filonenko A, Shteinberg M, Goeminne PC, Hill AT, Fardon TC, Obradovic D, Gerlinger C, Sotgiu G, Operschall E, Rutherford RM, Dimakou K, Polverino E, De Soyza A, McDonnell MJ.

Am J Respir Crit Care Med. 2018 Jun 1;197(11):1410-1420. doi: 10.1164/rccm.201711-2202OC.

PMID:
29357265
24.

Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis Network.

Chalmers JD, Ringshausen FC, Harris B, Elborn JS, Posthumus A, Haworth CS, Pilkington N, Polverino E, Ruddy T, Aliberti S, Goeminne PC, Winstanley C, De Soyza A.

Eur Respir J. 2018 Jan 11;51(1). pii: 1701937. doi: 10.1183/13993003.01937-2017. Print 2018 Jan. No abstract available.

PMID:
29326319
25.

Macrolides, mucoactive drugs and adherence for the management of bronchiectasis.

Chalmers JD, Polverino E; European Respiratory Society Bronchiectasis Guidelines Task Force.

Eur Respir J. 2018 Jan 4;51(1). pii: 1702033. doi: 10.1183/13993003.02033-2017. Print 2018 Jan. No abstract available.

PMID:
29301926
26.

Turning thirty: evolution but not revolution at the ERJ.

Kolb M, Chalmers JD.

Eur Respir J. 2018 Jan 4;51(1). pii: 1702594. doi: 10.1183/13993003.02594-2017. Print 2018 Jan. No abstract available.

PMID:
29301917
27.

The BRICS (Bronchiectasis Radiologically Indexed CT Score): A Multicenter Study Score for Use in Idiopathic and Postinfective Bronchiectasis.

Bedi P, Chalmers JD, Goeminne PC, Mai C, Saravanamuthu P, Velu PP, Cartlidge MK, Loebinger MR, Jacob J, Kamal F, Schembri N, Aliberti S, Hill U, Harrison M, Johnson C, Screaton N, Haworth C, Polverino E, Rosales E, Torres A, Benegas MN, Rossi AG, Patel D, Hill AT.

Chest. 2018 May;153(5):1177-1186. doi: 10.1016/j.chest.2017.11.033. Epub 2017 Dec 13.

PMID:
29247616
28.

Standardised classification of the aetiology of bronchiectasis using an objective algorithm.

Araújo D, Shteinberg M, Aliberti S, Goeminne PC, Hill AT, Fardon T, Obradovic D, Dimakou K, Polverino E, De Soyza A, McDonnell MJ, Chalmers JD.

Eur Respir J. 2017 Dec 14;50(6). pii: 1701289. doi: 10.1183/13993003.01289-2017. Print 2017 Dec. No abstract available.

PMID:
29242262
29.

Bronchiectasis Management: The State of the Union.

Chalmers JD, Restrepo MI.

Chest. 2017 Dec;152(6):1097-1099. doi: 10.1016/j.chest.2017.07.037. No abstract available.

PMID:
29223255
30.

Genetic mannose binding lectin deficiency is associated with airway microbiota diversity and reduced exacerbation frequency in COPD.

Dicker AJ, Crichton ML, Cassidy AJ, Brady G, Hapca A, Tavendale R, Einarsson GG, Furrie E, Elborn JS, Schembri S, Marshall SE, Palmer CNA, Chalmers JD.

Thorax. 2018 Jun;73(6):510-518. doi: 10.1136/thoraxjnl-2016-209931. Epub 2017 Nov 3.

31.

10 years since TORCH: shining a new light on the risks of inhaled corticosteroids in COPD.

Chalmers JD, Keir HR.

Eur Respir J. 2017 Sep 20;50(3). pii: 1701582. doi: 10.1183/13993003.01582-2017. Print 2017 Sep. No abstract available.

PMID:
28931673
32.

Patient participation in ERS guidelines and research projects: the EMBARC experience.

Chalmers JD, Timothy A, Polverino E, Almagro M, Ruddy T, Powell P, Boyd J.

Breathe (Sheff). 2017 Sep;13(3):194-207. doi: 10.1183/20734735.009517. Review.

33.

The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC): experiences from a successful ERS Clinical Research Collaboration.

Chalmers JD, Crichton M, Goeminne PC, Loebinger MR, Haworth C, Almagro M, Vendrell M, De Soyza A, Dhar R, Morgan L, Blasi F, Aliberti S, Boyd J, Polverino E.

Breathe (Sheff). 2017 Sep;13(3):180-192. doi: 10.1183/20734735.005117. Review.

34.

Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia.

Singanayagam A, Aliberti S, Cillóniz C, Torres A, Blasi F, Chalmers JD.

Eur Respir J. 2017 Sep 10;50(3). pii: 1602306. doi: 10.1183/13993003.02306-2016. Print 2017 Sep.

PMID:
28890433
35.

European Respiratory Society guidelines for the management of adult bronchiectasis.

Polverino E, Goeminne PC, McDonnell MJ, Aliberti S, Marshall SE, Loebinger MR, Murris M, Cantón R, Torres A, Dimakou K, De Soyza A, Hill AT, Haworth CS, Vendrell M, Ringshausen FC, Subotic D, Wilson R, Vilaró J, Stallberg B, Welte T, Rohde G, Blasi F, Elborn S, Almagro M, Timothy A, Ruddy T, Tonia T, Rigau D, Chalmers JD.

Eur Respir J. 2017 Sep 9;50(3). pii: 1700629. doi: 10.1183/13993003.00629-2017. Print 2017 Sep.

PMID:
28889110
36.

Profile of the ProAxsis active neutrophil elastase immunoassay for precision medicine in chronic respiratory disease.

Keir HR, Fong CJ, Dicker AJ, Chalmers JD.

Expert Rev Mol Diagn. 2017 Oct;17(10):875-884. doi: 10.1080/14737159.2017.1374174. Epub 2017 Sep 7.

PMID:
28854829
37.

A new free-cost e-service supporting clinicians to manage their difficult-to-treat tuberculosis cases: The European Respiratory Society-World Health Organization tuberculosis Consilium.

D'Ambrosio L, Tadolini M, Centis R, Chalmers JD, Migliori GB.

Indian J Med Res. 2017 Mar;145(3):261-263. doi: 10.4103/ijmr.IJMR_37_17. No abstract available.

38.

Oral versus intravenous clarithromycin in moderate to severe community-acquired pneumonia: an observational study.

Rae N, Singanayagam A, Schembri S, Chalmers JD.

Pneumonia (Nathan). 2017 Feb 5;9:2. doi: 10.1186/s41479-017-0025-2. eCollection 2017.

39.

High endocan levels are associated with the need for mechanical ventilation among patients with severe sepsis.

Mangat M, Amalakuhan B, Habib S, Reyes LF, Hinojosa CA, Rodriguez AH, Soni NJ, Anzueto A, Levine SM, Peters JI, Aliberti S, Sibila O, Rello J, Witzenrath M, Waterer GW, Martin-Loeches I, Blanquer J, Sanz F, Marcos PJ, Solé-Violán J, Chalmers JD, Feldman C, Wunderink RG, Cruz CSD, Orihuela CJ, Restrepo MI.

Eur Respir J. 2017 Jul 5;50(1). pii: 1700013. doi: 10.1183/13993003.00013-2017. Print 2017 Jul. No abstract available.

PMID:
28679609
40.

Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice.

Chalmers JD, Tebboth A, Gayle A, Ternouth A, Ramscar N.

NPJ Prim Care Respir Med. 2017 Jun 29;27(1):43. doi: 10.1038/s41533-017-0040-z.

41.

The past decade in bench research into pulmonary infectious diseases: What do clinicians need to know?

Finch S, Keir HR, Dicker AJ, Chalmers JD.

Respirology. 2017 Aug;22(6):1062-1072. doi: 10.1111/resp.13106. Epub 2017 Jun 28. Review.

42.

Severe Pneumococcal Pneumonia Causes Acute Cardiac Toxicity and Subsequent Cardiac Remodeling.

Reyes LF, Restrepo MI, Hinojosa CA, Soni NJ, Anzueto A, Babu BL, Gonzalez-Juarbe N, Rodriguez AH, Jimenez A, Chalmers JD, Aliberti S, Sibila O, Winter VT, Coalson JJ, Giavedoni LD, Dela Cruz CS, Waterer GW, Witzenrath M, Suttorp N, Dube PH, Orihuela CJ.

Am J Respir Crit Care Med. 2017 Sep 1;196(5):609-620. doi: 10.1164/rccm.201701-0104OC.

PMID:
28614669
43.

Anti-Pseudomonas aeruginosa IgG antibodies and chronic airway infection in bronchiectasis.

Suarez-Cuartin G, Smith A, Abo-Leyah H, Rodrigo-Troyano A, Perea L, Vidal S, Plaza V, Fardon TC, Sibila O, Chalmers JD.

Respir Med. 2017 Jul;128:1-6. doi: 10.1016/j.rmed.2017.05.001. Epub 2017 May 2.

PMID:
28610665
44.

Bronchiectasis and COPD Overlap: A Case of Mistaken Identity?

Chalmers JD.

Chest. 2017 Jun;151(6):1204-1206. doi: 10.1016/j.chest.2016.12.027. No abstract available.

PMID:
28599926
45.

Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research.

Hill AT, Haworth CS, Aliberti S, Barker A, Blasi F, Boersma W, Chalmers JD, De Soyza A, Dimakou K, Elborn JS, Feldman C, Flume P, Goeminne PC, Loebinger MR, Menendez R, Morgan L, Murris M, Polverino E, Quittner A, Ringshausen FC, Tino G, Torres A, Vendrell M, Welte T, Wilson R, Wong C, O'Donnell A, Aksamit T; EMBARC/BRR definitions working group.

Eur Respir J. 2017 Jun 8;49(6). pii: 1700051. doi: 10.1183/13993003.00051-2017. Print 2017 Jun.

PMID:
28596426
46.

A Randomized Controlled Trial of Atorvastatin in Patients With Bronchiectasis Infected With Pseudomonas Aeruginosa: A Proof of Concept Study.

Bedi P, Chalmers JD, Graham C, Clarke A, Donaldson S, Doherty C, Govan JRW, Davidson DJ, Rossi AG, Hill AT.

Chest. 2017 Aug;152(2):368-378. doi: 10.1016/j.chest.2017.05.017. Epub 2017 May 26.

47.

Macrolide resistance in Pseudomonas aeruginosa: implications for practice.

Chalmers JD.

Eur Respir J. 2017 May 19;49(5). pii: 1700689. doi: 10.1183/13993003.00689-2017. Print 2017 May. No abstract available.

PMID:
28526802
48.

Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease.

Dicker AJ, Crichton ML, Pumphrey EG, Cassidy AJ, Suarez-Cuartin G, Sibila O, Furrie E, Fong CJ, Ibrahim W, Brady G, Einarsson GG, Elborn JS, Schembri S, Marshall SE, Palmer CNA, Chalmers JD.

J Allergy Clin Immunol. 2018 Jan;141(1):117-127. doi: 10.1016/j.jaci.2017.04.022. Epub 2017 May 13.

49.

The heterogeneity of systemic inflammation in bronchiectasis.

Saleh AD, Chalmers JD, De Soyza A, Fardon TC, Koustas SO, Scott J, Simpson AJ, Brown JS, Hurst JR.

Respir Med. 2017 Jun;127:33-39. doi: 10.1016/j.rmed.2017.04.009. Epub 2017 Apr 17.

PMID:
28502416
50.

The microbiome in respiratory medicine: current challenges and future perspectives.

Faner R, Sibila O, Agustí A, Bernasconi E, Chalmers JD, Huffnagle GB, Manichanh C, Molyneaux PL, Paredes R, Pérez Brocal V, Ponomarenko J, Sethi S, Dorca J, Monsó E.

Eur Respir J. 2017 Apr 12;49(4). pii: 1602086. doi: 10.1183/13993003.02086-2016. Print 2017 Apr. Review.

PMID:
28404649

Supplemental Content

Loading ...
Support Center